RGD-independent Binding of Russell’s Viper Venom Kunitz-Type Protease Inhibitors to Platelet GPIIb/IIIa Receptor

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-44767-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Current Evidence for the Use of Platelet Gpiib/Iiia Receptor Inhibitors in Acute Coronary Syndromes

The Internet Journal of Anesthesiology
1999English

Clonal Restriction of Platelet-Associated Anti-GPIIb/IIIa Autoantibodies in Patients With Chronic ITP

Thrombosis and Haemostasis
Hematology
2001English

Kistrin, a Polypeptide Platelet GPIIb/IIIa Receptor Antagonist, Enhances and Sustains Coronary Arterial Thrombolysis With Recombinant Tissue-Type Plasminogen Activator in a Canine Preparation

Circulation
Cardiovascular MedicinePhysiologyCardiology
1991English

A New Platelet Polymorphism Duva+, Localized Within the RGD Binding Domain of Glycoprotein IIIa, Is Associated With Neonatal Thrombocytopenia

Blood
BiochemistryImmunologyCell BiologyHematology
2002English

Dynamics of GPIIb/IIIa-mediated Platelet-Platelet Interactions in Platelet Adhesion/Thrombus Formation on Collagen in Vitro as Revealed by Videomicroscopy

Blood
BiochemistryImmunologyCell BiologyHematology
2003English

Effect of Purified Russell’s Viper Venom-Factor X Activator (RVV-X) on Renal Hemodynamics, Renal Functions, and Coagulopathy in Rats

Toxicon
Toxicology
2011English

Establishment of Solid Phase GPIIb/IIIa Binding Assay Using Biotinylated Fibrinogen as a Ligand

Japanese Journal of Thrombosis and Hemostasis
1991English

Viper Venom for Diabetic Nephropathy

Kidney International
Nephrology
2012English

Off-Target Effects of Glycoprotein IIb/IIIa Receptor Inhibitors

Cardiology Journal
MedicineCardiovascular MedicineCardiology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy